Callaghan Innovation

Eight ANZ startups that raised $373.3 million this week

Weekly roundup detailing eight trans-Tasman raises totalling A$373.3 million, headlined by Halter's Series E, spanning quantum computing, biomanufacturing, robotics, adtech and agtech, plus a recalled $2 billion founder exit.

Also Startup Daily

Four ANZ startups that raised $26.9 million this week

Weekly roundup of four ANZ raises: Conflux Technology's $11 million Series B, BuildPass's $7.5 million seed, Projectworks's US$5 million Series A alongside a CEO change, and DNAiTECH's NZ$1 million round.

Also Startup Daily

Over $15m invested in world-leading cancer immunotherapy

Auckland University spinout TamoRx has secured NZ$15.25 million to develop a new cancer immunotherapy, in a round led by Brandon Capital alongside the university's Inventors' Fund, with a Callaghan Innovation grant included.

Boosting product confidence of a world-leading RNA therapeutics start-up

Case study on how CSIRO's bioinformatics teams independently validated the cancer-target findings of Amaroq Therapeutics, a New Zealand biotech whose $14m seed round was funded by the Brandon Capital-managed MRCF and others.

Boosting product confidence of a world-leading RNA therapeutics start-up

New Zealand cancer biotech Amaroq Therapeutics had its lncRNA drug targets independently validated by CSIRO, according to this profile, which also recalls its $14 million seed round and support from Callaghan Innovation.

Kiwi agritech startup Protag raises $1m

New Zealand agritech Protag raised NZ$1 million, led by Sprout with Finistere Ventures, Fonterra and OurCrowd, for smart ear tags monitoring dairy cow health and behaviour.

Also Startup Daily